The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-(1H-Indol-3-yl)-N-(2-nitrophenyl)-1,3,4-oxadiazol-2-amine ID: ALA4102399
Chembl Id: CHEMBL4102399
PubChem CID: 137659638
Max Phase: Preclinical
Molecular Formula: C16H11N5O3
Molecular Weight: 321.30
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=[N+]([O-])c1ccccc1Nc1nnc(-c2c[nH]c3ccccc23)o1
Standard InChI: InChI=1S/C16H11N5O3/c22-21(23)14-8-4-3-7-13(14)18-16-20-19-15(24-16)11-9-17-12-6-2-1-5-10(11)12/h1-9,17H,(H,18,20)
Standard InChI Key: KMBFUJJRYOMMRA-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 321.30Molecular Weight (Monoisotopic): 321.0862AlogP: 3.87#Rotatable Bonds: 4Polar Surface Area: 109.88Molecular Species: ACIDHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.48CX Basic pKa: ┄CX LogP: 4.44CX LogD: 2.85Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.44Np Likeness Score: -1.58
References 1. Hamdy R, Ziedan NI, Ali S, Bordoni C, El-Sadek M, Lashin E, Brancale A, Jones AT, Westwell AD.. (2017) Synthesis and evaluation of 5-(1H-indol-3-yl)-N-aryl-1,3,4-oxadiazol-2-amines as Bcl-2 inhibitory anticancer agents., 27 (4): [PMID:28087272 ] [10.1016/j.bmcl.2016.12.061 ] 2. Liu T, Wu Z, He Y, Xiao Y, Xia C.. (2020) Single and dual target inhibitors based on Bcl-2: Promising anti-tumor agents for cancer therapy., 201 [PMID:32563811 ] [10.1016/j.ejmech.2020.112446 ]